Healthcare / Health Information ServicesShenzhen
$3.84
-0.12 (-3.03%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-193.5M · quality 69.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
18/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.9B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-10.0%
↓Gross Margin
35.6%
↓Debt/Equity
0.02
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-11.7%
FCF CAGR
—
FCF margin
-18.4%
FCF / Net income
0.48x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.05B · net income $-401.7M · FCF $-193.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.05B | $1.05B | $1.42B | $1.62B | $1.53B |
| Net Income | $-401.7M | $-401.7M | $-173.5M | $36.7M | $42.6M |
| EBITDA | $-237.4M | $-237.4M | $-6.8M | $163.1M | $142.3M |
| EPS | -0.26 | -0.26 | -0.11 | 0.02 | 0.03 |
| Gross Margin | 35.6% | 35.6% | 45.2% | 47.0% | 49.4% |
| Operating Margin | -17.0% | -17.0% | 3.7% | 12.3% | 16.7% |
| Net Margin | -38.2% | -38.2% | -12.2% | 2.3% | 2.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.02 | 0.02 | 0.01 | 0.00 | 0.02 |
| Current Ratio | 2.41 | 2.41 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-193.5M | $-193.5M | $-128.0M | $-234.0M | $-174.8M |
| Returns | |||||
| ROE | -10.0% | -10.0% | -3.9% | 0.8% | 0.9% |
| Valuation | |||||
| P/E | — | — | — | 306.50 | 275.33 |
| EV/EBITDA | — | — | — | 62.35 | 72.83 |
| P/B | 1.48 | 1.48 | 1.49 | 2.44 | 2.56 |
| Growth & Yield | |||||
| Revenue Growth | -26.1% | -26.1% | -12.0% | 5.8% | — |
| EPS Growth | -136.4% | -136.4% | -650.0% | -33.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.11 → -0.26
Residual
-29.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.